Intestinal Permeability and Endometriosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Garrett Lam, MD
UT College of Medicine
Study Chair - Patti Bush, EdD
UT College of Medicine
Study Director - Shanti Mohling, MD
UT College of Medicine
Principal Investigator - Steve Radtke, MD
UT College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Erlanger Medical Center
Chattanooga, Tennessee, United States
- Women'S Surgery Center
Chattanooga, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2016
- Primary completion
- 30 Jun 2019
- Completion
- 30 Jun 2019
- Last update posted
- 28 Apr 2020
- Registered enrollment
- 46
- Registry id
- NCT03042923
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.